Correlation Between ANI Pharmaceuticals and Evotec SE

Can any of the company-specific risk be diversified away by investing in both ANI Pharmaceuticals and Evotec SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ANI Pharmaceuticals and Evotec SE into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ANI Pharmaceuticals and Evotec SE ADR, you can compare the effects of market volatilities on ANI Pharmaceuticals and Evotec SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ANI Pharmaceuticals with a short position of Evotec SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of ANI Pharmaceuticals and Evotec SE.

Diversification Opportunities for ANI Pharmaceuticals and Evotec SE

-0.21

Correlation Coefficient

ANI Pharmaceuticals  Evotec SE

Very good diversification

The 3 months correlation between ANI and Evotec is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding ANI Pharmaceuticals and Evotec SE ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evotec SE ADR and ANI Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ANI Pharmaceuticals are associated (or correlated) with Evotec SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evotec SE ADR has no effect on the direction of ANI Pharmaceuticals i.e., ANI Pharmaceuticals and Evotec SE go up and down completely randomly.

Pair Corralation between ANI Pharmaceuticals and Evotec SE

Given the investment horizon of 90 days ANI Pharmaceuticals is expected to under-perform the Evotec SE. But the stock apears to be less risky and, when comparing its historical volatility, ANI Pharmaceuticals is 2.34 times less risky than Evotec SE. The stock trades about -0.05 of its potential returns per unit of risk. The Evotec SE ADR is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  345.00  in Evotec SE ADR on September 2, 2024 and sell it today you would earn a total of  124.00  from holding Evotec SE ADR or generate 35.94% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

ANI Pharmaceuticals  vs.  Evotec SE ADR

ANI Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ANI Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's forward indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Evotec SE ADR

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Evotec SE ADR are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Evotec SE displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with ANI Pharmaceuticals and Evotec SE

The main advantage of trading using opposite ANI Pharmaceuticals and Evotec SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ANI Pharmaceuticals position performs unexpectedly, Evotec SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evotec SE will offset losses from the drop in Evotec SE's long position.

The idea behind ANI Pharmaceuticals and Evotec SE ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.